| AIC | Akaike Information Criterion |
| ALC | Absolute Lymphocyte Count |
| axi-cel | Axicabtagene Ciloleucel |
| CAR-T | Chimeric Antigen Receptor T-cell |
| CI | Confidence Interval |
| CMV | Cytomegalovirus |
| CRP | C-Reactive Protein |
| CRS | Cytokine Release Syndrome |
| CTCAE | Common Terminology Criteria for Adverse Events |
| DLBCL | Diffuse Large B-Cell Lymphoma |
| ECOG | Eastern Cooperative Oncology Group |
| ER | Emergency Room |
| HCT-CI | Hematopoietic Cell Transplantation–Comorbidity Index |
| ICANS | Immune Effector Cell-Associated Neurotoxicity Syndrome |
| ICU | Intensive Care Unit |
| IRR | Incidence Rate Ratio |
| LBCL | Large B-Cell Lymphoma |
| LDH | Lactate Dehydrogenase |
| LOS | Length of Stay |
| NB | Negative Binomial |
| OP | Outpatient |
| OR | Odds Ratio |
| PET0 | Baseline PET Scan |
| PET30 | Day 30 PET Scan |
| PR | Partial Response |
| R/R | Relapsed/Refractory |
| SD | Standard Deviation |
| SUVmaxD30 | Maximum Standardized Uptake Value at Day 30 |
| tisa-cel | Tisagenlecleucel |
| VIF | Variance Inflation Factor |